Artivion Overview

  • Year Founded
  • 1984

Year Founded

  • Status
  • Public

  • Employees
  • 1,800

Employees

  • Stock Symbol
  • AORT

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $18.53
  • (As of Thursday Closing)

Artivion General Information

Description

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Contact Information

Formerly Known As
CryoLife, Inc., CryoLife Incorporation, Cry o life, CryoLife
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 1655 Roberts Boulevard, North West
  • Kennesaw, GA 30144
  • United States
+1 (770)
Primary Industry
Surgical Devices
Stock Exchange
NYS
Corporate Office
  • 1655 Roberts Boulevard, North West
  • Kennesaw, GA 30144
  • United States
+1 (770)

Artivion Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Artivion Stock Performance

As of 19-Nov-2026, Artivion’s stock price is $18.53. Its current market cap is $904M with 48.8M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.53 $18.54 $18.11 - $48.25 $904M 48.8M 670K -$0.36

Artivion Financials Summary

As of 30-Sep-2026, Artivion has a trailing 12-month revenue of $482M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,443,268 2,349,334 1,505,432 1,037,971
Revenue 481,876 441,330 388,537 354,004
EBITDA 41,129 63,057 49,501 25,712
Net Income (17,593) 9,768 (13,359) (30,690)
Total Assets 1,042,088 884,796 789,101 792,397
Total Debt 407,027 257,614 362,258 358,341
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Artivion Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Artivion‘s full profile, request access.

Request a free trial

Artivion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Ao
Surgical Devices
Kennesaw, GA
1,800 As of 2025

South Jordan, UT
 

Eagan, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Artivion Competitors (33)

One of Artivion’s 33 competitors is Merit Medical Systems, a Corporation company based in South Jordan, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merit Medical Systems Corporation South Jordan, UT
Anteris Technologies Corporation Eagan, MN
Orthofix Medical Formerly PE-Backed Lewisville, TX
Medtronic Corporation Minneapolis, MN
Atricure Formerly VC-backed Mason, OH
You’re viewing 5 of 33 competitors. Get the full list »

Artivion Patents

Artivion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3094812-A1 Central nervous system localized hypothermia apparatus and methods Pending 22-Mar-2018
WO-2019183464-A1 Central nervous system localized hypothermia apparatus and methods Inactive 22-Mar-2018
AU-2017206020-A1 Human placental tissue graft products, methods, and apparatuses Active 08-Jan-2016
AU-2017206020-B2 Human placental tissue graft products, methods, and apparatuses Active 08-Jan-2016
AU-2021245207-A1 Human placental tissue graft products, methods, and apparatuses Inactive 08-Jan-2016 A61L27/60
To view Artivion’s complete patent history, request access »

Artivion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Artivion Investments & Acquisitions (11)

Artivion’s most recent deal was a Merger/Acquisition with Endospan for . The deal was made on 18-May-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Endospan 18-May-2026 Merger/Acquisition Surgical Devices
Ascyrus Medical 02-Sep-2020 Merger/Acquisition Therapeutic Devices
Jotec 01-Dec-2017 Merger/Acquisition Surgical Devices
Genesee BioMedical (PhotoFix Surgery Product) 14-Apr-2016 Corporate Asset Purchase Buildings and Property
On-X 20-Jan-2016 Merger/Acquisition Surgical Devices
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

Artivion ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

31.78 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Artivion’s complete esg history, request access »

Artivion Exits (4)

Artivion’s most recent exit was on 27-Mar-2014 from CryoLife (ProCol). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
CryoLife (ProCol) 27-Mar-2014 Completed
ValveXchange 01-Jan-2012 Completed
ValveXchange 01-Jan-2012 Completed
ValveXchange 01-Jul-2011 Corporate Completed
To view Artivion’s complete exits history, request access »

Artivion Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Endospan Herzliya, Israel 2009
Hemosphere Eden Prairie, MN 1998

Artivion FAQs

  • When was Artivion founded?

    Artivion was founded in 1984.

  • Where is Artivion headquartered?

    Artivion is headquartered in Kennesaw, GA.

  • What is the size of Artivion?

    Artivion has 1,800 total employees.

  • What industry is Artivion in?

    Artivion’s primary industry is Surgical Devices.

  • Is Artivion a private or public company?

    Artivion is a Public company.

  • What is Artivion’s stock symbol?

    The ticker symbol for Artivion is AORT.

  • What is the current stock price of Artivion?

    As of 19-Nov-2026 the stock price of Artivion is $18.53.

  • What is the current market cap of Artivion?

    The current market capitalization of Artivion is $904M.

  • What is Artivion’s current revenue?

    The trailing twelve month revenue for Artivion is $482M.

  • Who are Artivion’s competitors?

    Merit Medical Systems, Anteris Technologies, Orthofix Medical, Medtronic, and Atricure are some of the 33 competitors of Artivion.

  • What is Artivion’s annual earnings per share (EPS)?

    Artivion’s EPS for 12 months was -$0.36.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process